Eloise Jarvis

Lead Analyst Beacon Intelligence

Eloise Jarvis holds an MSci in Biochemistry & Molecular Biology from University College London, where her research project examined tau biology and extracellular vesicle–mediated protein propagation in neurodegeneration. As Lead Research Analyst for the Neuroscience module at Beacon, she provides comprehensive intelligence analysis across the neuroscience landscape to support drug development and research strategy.

Seminars

Wednesday 3rd June 2026
A Landscape Review of ALS Therapy Development
3:40 pm
  • The drug landscape, displaying critical data-driven therapeutic and clinical trial highlights, as well as current trends
  • A look at the developer landscape, allowing for understanding of the commercial market involving these drugs’ development
  • The outlook for the future of the ALS therapeutics field from a preclinical and clinical perspective
Eloise Jarvis, Researcher, Beacon Intelligence - Expert Speaker at the 5th ALS Drug Development Summit 2026